PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA. Simchaweissman@gmail.com.\', \'Division of Gastroenterology and Hepatology, University of Toledo Medical Center, Toledo, OH, USA.\', \'Department of Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA.\', \'Division of Gastroenterology, Inflammatory Bowel Disease Program, Lenox Hill Hospital, Northwell Health, New York, NY, USA.\', \'Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00384-021-03977-9
?:doi
?:hasPublicationType
?:journal
  • International journal of colorectal disease
is ?:pmid of
?:pmid
?:pmid
  • 34131784
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.054
?:rankingScore_hIndex
  • 76
?:title
  • Safety of biologics in inflammatory bowel disease patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34131784>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34131784>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all